SI1098639T1 - - Google Patents

Info

Publication number
SI1098639T1
SI1098639T1 SI9930772T SI9930772T SI1098639T1 SI 1098639 T1 SI1098639 T1 SI 1098639T1 SI 9930772 T SI9930772 T SI 9930772T SI 9930772 T SI9930772 T SI 9930772T SI 1098639 T1 SI1098639 T1 SI 1098639T1
Authority
SI
Slovenia
Application number
SI9930772T
Inventor
Antoine M A Bril
Robin Edwin Buckingham
Nassirah Khandoudi
Original Assignee
Smithkline Beecham Plc
Glaxosmithkline Lab Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en
Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en
Priority claimed from GBGB9905387.8A external-priority patent/GB9905387D0/en
Application filed by Smithkline Beecham Plc, Glaxosmithkline Lab Sas filed Critical Smithkline Beecham Plc
Publication of SI1098639T1 publication Critical patent/SI1098639T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9930772T 1998-07-21 1999-07-21 SI1098639T1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9815871.0A GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound
GBGB9815872.8A GB9815872D0 (en) 1998-07-21 1998-07-21 Novel method
GBGB9905387.8A GB9905387D0 (en) 1999-03-09 1999-03-09 Novel method
EP99934914A EP1098639B1 (en) 1998-07-21 1999-07-21 Use of the glucose uptake enhancer rosiglitazone for reducing ischaemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells
PCT/GB1999/002361 WO2000004890A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis

Publications (1)

Publication Number Publication Date
SI1098639T1 true SI1098639T1 (ko) 2005-08-31

Family

ID=27269407

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930772T SI1098639T1 (ko) 1998-07-21 1999-07-21

Country Status (26)

Country Link
EP (2) EP1516617A2 (ko)
JP (1) JP2002521326A (ko)
KR (1) KR20010079551A (ko)
CN (1) CN1310620A (ko)
AP (1) AP2001002036A0 (ko)
AT (1) ATE288746T1 (ko)
AU (1) AU5053799A (ko)
BG (1) BG105250A (ko)
BR (1) BR9912117A (ko)
CA (1) CA2338211A1 (ko)
DE (1) DE69923687T2 (ko)
DK (1) DK1098639T3 (ko)
EA (1) EA200100165A1 (ko)
ES (1) ES2237929T3 (ko)
HK (1) HK1037865A1 (ko)
HU (1) HUP0103199A3 (ko)
ID (1) ID26986A (ko)
IL (1) IL140664A0 (ko)
NO (1) NO20010292L (ko)
OA (1) OA11579A (ko)
PL (1) PL345627A1 (ko)
PT (1) PT1098639E (ko)
SI (1) SI1098639T1 (ko)
SK (1) SK1012001A3 (ko)
TR (1) TR200100207T2 (ko)
WO (1) WO2000004890A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3073700A (en) * 1999-01-19 2000-08-07 Sankyo Company Limited Troglitazone-containing medicinal compositions for inhibiting apoptosis
CA2382966A1 (en) 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
JPH05202042A (ja) * 1992-01-24 1993-08-10 Sankyo Co Ltd 糖尿病性合併症治療剤
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments
US6277819B1 (en) * 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
CZ74199A3 (cs) * 1996-09-12 1999-07-14 Sankyo Company Limited Činidlo pro zvýšení aktivity glutathionreduktasy
GB9721692D0 (en) * 1997-10-13 1997-12-10 Smithkline Beecham Plc Novel treatment
EP1047423B1 (en) * 1997-11-19 2006-05-10 Takeda Pharmaceutical Company Limited Novel apoptosis inhibitors
AU2781899A (en) * 1998-02-24 1999-09-15 Trustees Of The University Of Pennsylvania, The Use of a cardiac purinoceptor to effect cellular glucose uptake
WO1999059586A1 (en) * 1998-05-19 1999-11-25 Regents Of The University Of California Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
US5968960A (en) * 1999-01-14 1999-10-19 The Regents Of The University Of California Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

Also Published As

Publication number Publication date
CA2338211A1 (en) 2000-02-03
EP1098639A1 (en) 2001-05-16
NO20010292D0 (no) 2001-01-18
BG105250A (en) 2001-11-30
EA200100165A1 (ru) 2001-08-27
KR20010079551A (ko) 2001-08-22
AP2001002036A0 (en) 2001-03-31
JP2002521326A (ja) 2002-07-16
NO20010292L (no) 2001-03-08
DE69923687T2 (de) 2006-04-06
ATE288746T1 (de) 2005-02-15
EP1516617A2 (en) 2005-03-23
EP1098639B1 (en) 2005-02-09
SK1012001A3 (en) 2001-08-06
BR9912117A (pt) 2001-04-10
CN1310620A (zh) 2001-08-29
PT1098639E (pt) 2005-06-30
ES2237929T3 (es) 2005-08-01
AU5053799A (en) 2000-02-14
DK1098639T3 (da) 2005-06-13
HUP0103199A3 (en) 2002-08-28
IL140664A0 (en) 2002-02-10
TR200100207T2 (tr) 2001-05-21
HUP0103199A2 (hu) 2002-05-29
ID26986A (id) 2001-02-22
WO2000004890A1 (en) 2000-02-03
DE69923687D1 (de) 2005-03-17
PL345627A1 (en) 2002-01-02
HK1037865A1 (en) 2002-02-22
OA11579A (en) 2004-06-01

Similar Documents

Publication Publication Date Title
BE2012C041I2 (ko)
BE2009C051I2 (ko)
BRPI9917862A2 (ko)
JP2001512925A5 (ko)
DK7498A (ko)
JP2002521368A5 (ko)
BRPI9816295A2 (ko)
BRPI9917863A2 (ko)
JP2543489C (ko)
JP2532805C (ko)
IN191606B (ko)
JP2550702C (ko)
JP2511845C (ko)
JP2561988C (ko)
JP2564843C (ko)
JP2610919C (ko)
IN187719B (ko)
CN3072756S (ko)
CN3073964S (ko)
CL1998003164A1 (ko)
SI1098639T1 (ko)
CN3090185S (ko)
CN3072688S (ko)
CN3089187S (ko)
CN3081515S (ko)